Skip to content
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM

Our Publications

  • Our Broadcasts
  • Our Publications
  • Our Analyses
digitalstudios2021-06-15T19:18:01+00:00

Global M&A Snaps Back, A Strong 2011 Expected (March 1, 2011 Chemical Week)

Discussion and data on the surge in chemical M&A activity

digitalstudios2021-06-15T19:18:54+00:00

Genzyme Completes Sale of Pharmaceutical Ingredients Business (February 28, 2011)

Genzyme press release announcing the completion of the sale and Y&P advisory role

digitalstudios2021-06-15T19:19:46+00:00

Tronox Emerges Successfully From Bankruptcy – Young & Partners was financial advisor to the Equity Committee (February 14, 2011)

Y&P press release announcing its advisory role resulting in the successful emergence of Tronox from bankruptcy

digitalstudios2021-06-15T19:20:30+00:00

Genzyme Agrees to Sell Pharmaceuticals Business to International Chemical Investors Group (February 1, 2011)

Genzyme press release announcing the signing of an agreement to sell its Pharmaceutical Ingredients Business and Y&P's advisory role

digitalstudios2021-06-15T19:25:35+00:00

Young & Partners Article on Improving Chemical Financing Markets in ICIS Chemical Business (December 10, 2010)

Y&P article describing what is driving the recovery of the debt financing market, but the storm clouds that are appearing

digitalstudios2021-06-15T19:26:22+00:00

Arizona Chemical Deal Press Release (November 19, 2010)

Press release covering the completion of the Arizona Chemical transaction and Y&P’s role as advisor to American Securities

digitalstudios2021-06-15T19:27:11+00:00

Tronox Reaches Settlement With Equity Committee – Young & Partners acts as financial advisor to the Equity Committee (November 3, 2010)

Tronox Equity Committee reaches settlement with debtor and debt holders with regard to the reorganization plan

digitalstudios2021-12-03T20:13:15+00:00

Pharma Deals on a Diet (Pharmaceutical Executive November 2010)

Y&P annual life sciences review of Pharma and Biotech M&A and financial developments, highlighting an active M&A but smaller deal market

digitalstudios2021-12-03T20:14:37+00:00

The Chemical Financing Market Remains Choppy Despite Improvements (ICIS Chemical Business August 2010)

High yield surges as market seeks yield, but equity and senior debt markets are anemic

digitalstudios2021-12-03T20:12:36+00:00

China – Behind the Screen (Pharmaceutical Executive July 2010)

Editor-in-Chief interviews Peter Young who provides overview of the structure and dynamics of the Chinese pharmaceutical market

Previous161718Next

DISCLAIMER

JOIN OUR MAILING LIST

© YOUNG & PARTNERS LLC   |   535 Fifth Avenue, 4th Floor, New York, New York 10017 | 212-682-5555

Page load link
Go to Top